Zevra Therapeutics to Present at the Piper Sandler Annual Healthcare Conference
Key Highlights
- ➤Zevra executives will present at Piper Sandler’s healthcare conference December 2, 2026
- ➤Presentation scheduled for 1:00 p.m. ET in New York
- ➤Management will hold one-on-one meetings with registered conference attendees
- ➤Zevra markets its lead product in the U.S. for Niemann-Pick disease type C
BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company committed to redefining what's possible in bringing life-changing therapeutics to people living with rare diseases, today announced that members of Zevra’s executive leadership team will present at the Piper Sandler 38(th) Annual Healthcare Conference in New York, NY on Wednesday, December 2, 2026, at 1:00 p.m. ET.
Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com.
Get started
Create a free account to read the full story.
